Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Moderna (MRNA) Extends Gain After Earnings, Up 6%
February 24, 2022 9:08 AM ESTModerna (NASDAQ: MRNA) Extends Gain After Earnings, Up 6%
Moderna (MRNA) Tops Q4 EPS by $1.39, Announces $3 billion share repurchase plan
February 24, 2022 7:00 AM ESTModerna (NASDAQ: MRNA) reported Q4 EPS of $11.29, $1.39 better than the analyst estimate of $9.90. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.78 billion.
Moderna announces a new $3 billion share repurchase planFor earnings history and earnings-related data on Moderna (MRNA) click here.
... More


